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Abstract 
The low molecular weight thiols present in the deproteinized extract of a 
prostate cancer cell line (LNCaP-FGC) were analysed after derivatization with 
the Ellman reagent (ESSE). The mixed disulphides formed (RSSE) were frac-
tionated, characterized and quantified by liquid chromatography on a C-18 
column using UV detection. This revealed the presence, in femtomoles per 
cell, of glutathione (8.30 ± 0.73), cysteine (2.71 ± 0.04) and cysteinylglycine 
(0.83 ± 0.10), accounting for the bulk of the thiol present. Further analysis of 
the cell extracts using a novel and sensitive mass spectrometry technique al-
lowed the detection of low level of an additional derivative which was identi-
fied as cysteinylglycerate using NMRspectroscopy. 
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1. Introduction 
In the Western world, prostate cancer is a significant burden to men’s health. It 
represents the most frequently diagnosed nondermatological malignancy and 
the second cause of death due to cancer in men [1] [2]. Fresh research on its 
genesis and detection is therefore a matter of some priority. 
Currently, there is much interest in the role of oxidative stress in prostate 
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cancer development and progression [for reviews see [3] and [4]]. Thiols play 
major roles and many important cellular metabolic processes and reactions [e.g. 
[5]]; in particular the low molecular weight thiols (LMWT) are responsible for 
the maintenance of oxidation/reduction (redox) levels in cells. The dynamic re-
lationship between the LMWT, particularly glutathione (GSH), and reactive 
oxygen species (ROS) underpins redox regulation and signalling [6] [7]. With 
regard to prostate cancer, the recent work of Oberley’s group [8] [9] has illus-
trated the role of cellular thiol components on the cell redox state and oxidative 
stress in the genesis and drug metabolism of prostate cancer cell lines. 
It is therefore believed that further knowledge regarding the cellular metabo-
lism of LMWT may help in the rational design of new more efficacious drugs to 
treat prostate cancer metastases. 
Most studies on cellular LMWT have centred around the tripeptide GSH, the 
metabolism of which has been studied in detail over the last century and it is now 
widely accepted as the major LMWT present in eukaryote cells [10]. This tripep-
tide has been shown to have many roles in cellular metabolism; particularly with 
regard to its protective roles [11], cancer progression and chemoresistance [12]. 
However, earlier studies on the composition of tumor cell LMWT have re-
vealed the presence of other thiols which could have important roles in tumor 
cell metabolism. Investigations on the LMWT found in the acid soluble fraction 
(ASF) of currently untreatable metastatic human prostate cancer cells indicated 
the presence of significant quantities of thiol components other than glutathione 
which were not identified [13]. In this paper, we report an in depth reinvestiga-
tion of these findings using more up to date techniques. 
To facilitate this analysis and to avoid the formation of oxidation artefacts, the 
ASFthiols (RSH) have been labelled with the Ellman reagent (ESSE) [14] to give 
stable mixed disulfide derivatives (RSSE) [15] as shown in . 
The mixed disulfides (RSSE) formed from the LNCaP cell ASF were analysed 
and quantified by UHPLC-UV at 325 nm. An unknown component was also de-
tected in this system and identified by mass spectrometry and NMR spectroscopy. 
2. Materials and Methods 
2.1. Chemicals 
L-cysteine (CYS), N-acetyl-cysteine (NAC), cysteinylglycine (CYSGLY), homo-
cysteine (HCYS), cysteamine (CYSAM) and glutathione (GSH), 5’5 dithiobis 
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. Reaction of the Ellman reagent (ESSE) with thiols (RSH). 
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(-2-nitrobenzoic acid) (ESSE), trichloroacetic acid (TCA) and sodium phosphate 
were purchased from Sigma-Aldrich Ltd (Poole, Dorset, UK). All solutions were 
made using 18.2 mΩ-cm2 water, prepared on site by Diamond Lab Water System 
(Triple Red Laboratory Technology, Bucks, UK) LC-MS grade methanol was 
obtained from Fisher Scientific UK Ltd (Bishop Meadow Road, Loughborough.) 
2.2. Cell Culture 
A lymph node prostate cancer cell line (LNCaP, clone FGC-ECAC no. 89110211)) 
was supplied byPublic Health England (PHE) at Porton Down, UK. The cells 
were grown in RPMI 1640 medium supplemented with 2 mM glutamine, 1 mM 
sodium pyruvate and 10% v/v zone 2 foetal bovineserum. When at 80% conflu-
ence fresh medium was added and 2 hours later the cells were harvested with 
trypsin. After centrifuging the pellets down from the trypsin solution they were 
stored at −80˚C pending analysis. 
2.3. Preparation of Ellman Mixed Disulfides 
A) From known biological low molecular weight thiols 
Stock solutions of GSH, CYS, CYSGLY, HCYS and NAC were prepared in 
18.2 mΩ-cm2 water at an accurately known concentration (ca 2.0 mM). Calibra-
tion standards were prepared by mixing and then serially diluting the aqueous 
stock solutions. 350 µL of diluted standard mixture was transferred to a 1.5 ml 
micro-centrifuge tube. 50 µL of internal standard solution was added to each 
tube followed by 400 µL of 5 mM ESSE solution (in 0.4 mM phosphate buffer, 
pH 7.6). Each tube was vortexed briefly to mix the contents. 200 µL of 50% w/v 
TCA was added and the tube was vortexed for 10 seconds then centrifuged at 
14,000 rpm at +4˚C for 20 minutes. The supernatant was collected and trans-
ferred to a LC vials in a cooled auto sampler (+4˚C) for injection. [It was found 
that analysis of these mixed disulfides had to be carried as soon as possible after 
preparation to avoid artifact formation from the excess ESSE and ES present in 
the mixture]. 
B) From cells 
Cell pellets were defrosted at room temperature over 5 minutes. Each pellet 
was re-suspended in 400 µL of cold deionised water by briefly aspirating then 2 × 
10 µl aliquots were taken for cell counting using a C-Chip® disposable haemocy-
tometer. 350 µl of the cell suspension was transferred to a 1.5 ml micro-centrifuge 
tube. Blanks were prepared using 350 µl deionised water in place of cell suspen-
sion. 50 µl of internal standard solution was added to each tube followed by 400 
µl 5 mM ESSE solution (in 0.4 mM phosphate buffer, pH 7.6). Tubes were vor-
texed briefly to mix the contents. The cells were lysed on ice using a sonic probe 
(SoniPrep) on full power for 5 cycles of 10 seconds at an interval of 10 seconds. 
After vortexing for 15 seconds the tubes were returned to ice for 5 minutes. 200 
µl of 50% w/v TCA were added followed by vortexing for 10 seconds. The mix-
ture was then centrifuged at 14,000 rpm at 4˚C for 20 minutes and the super-
natant transferred to LC vials and placed in a cooled auto sampler (+4˚C) prior 
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to injection. 
2.4. Ultra-High Performance Liquid Chromatography Analysis 
Gradient UHPLC was performed on an integrated Agilent 1290 UHPLC system, 
using a TITAN™ C18 column (1.8 µm, 100 mm × 2.1 mm), (Supelco, Sigma Al-
drich.) The flow rate was 0.7 ml/min and the injection volume was 1 µL. A post 
injection needle wash was included in the method to rinse for 3 seconds with 
MeOH. Column temperature was automatically regulated at 35˚C. Mobile phase 
A consisted of 0.1% v/v formic acid (HCOOH) in 18.2 mΩ-cm2 water. Mobile 
phase B was 0.1% v/v formic acid in LC MS grade methanol. The gradient elu-
tion profile of 0 mins, 0% B; 6 mins, 2% B; 15 mins, 20% B; 18 mins, 90% B; 20 
mins, 90% B; 22 mins, 0% B. The post time was 5 minutes at 0% B was used. 
Primary detection and quantification of RSSE components by UV was per-
formed at 325 nm using a semi micro flow-cell. Details of this method are given 
as supplementary information. 
The UV absorbing peaks detected were examined by mass spectrometry using 
an Agilent 6540 UHD QToF-MS operating in negative mode with Agilent Dual 
Jet Stream (ASJ) electrospray ionisation (ESI). The system was programmed to 
scan the mass range from 50 to 1700 with a scan rate of 3 spectra per second. 
The source parameters were as follows: Gas Temperature, 250˚C; Gas Flow, 8 
l/min; Nebulizer Pressure, 25 psig; Sheath Gas Temperature, 325˚C; Sheath Gas 
Flow, 10 l/min. During analysis of thiol derivatives only, the collision cell energy 
was set to 10 and the fragmentation was set to 50.0 V. Mass accuracy was main-
tained during the run by infusion of mass calibration ions. 
LC-MS operation was managed, and data collected, using Agilent Masshunter 
Acquisition Software B. 06. MS data was processed and analysed by Agilent 
Masshunter Qualitative Analysis Software B. 06. Significance testing and fold- 
change analysis of the data was performed using Mass Profiler Pro (Agilent 
Technologies, Delaware, USA). 
A synopsis of the development of the MS compatible LC methodology is given 
in the supplementary information. 
2.5. Semi Scaled Preparative HPLC 
This was carried out on an integrated Agilent 1290 UHPLC system. ACE C1Co8 
(250 × 10 mm, 5 µM). Column Temperature: Ambient (18˚C). Mobile Phase: 
(A): 0.1% HCOOH in H20, (B): 0.1% HCOOH in MeOH. Flow Rate: 8.00 
ml/min. Gradient: 0 min 10% B; 11.88 min 50% B; 14.77 min 90% B; 17.72 min 
90% B; 20.68 min 10% B; 23.63 min 10% B. Post-time: 10 min. UV: 325 nm. 
After repeated injections the pooled sample peaks were freeze dried and re-
suspended in 100% D2O for NMR analysis. 
2.6. NMR Spectroscopy 
1H NMR data were recorded on a Bruker AVANCE III NMR spectrometer at 
500.13 MHz at 300 K by using a 5-mm BBI probe equipped with a z-gradient 
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coil. 
A relaxation delay, 2.4 s; acquisition time, 1.6 s; spectral window 10 000 Hz, 32 
768 data points and a number of 128 scans were used to collect the data. A 0.5 
Hz line broadening procedure was applied before Fourier transformation, and 
baseline correction was performed before integration with Bruker software. The 
methanol signal was used as an internal reference for chemical shift (3.3 ppm). 
The signal from residual water was used as an internal reference for chemical 
shift (4.7 ppm). 
3. Results 
3.1. Quantification of Thiols Derivatives in LNCaP by UHPLC-UV 
Implementation of a 10 cm × 2.1 mm, 1.8 um TITAN UHPLC column and sub-
sequent modification of the gradient resulted in resolution of all standard thiol 
derivatives in addition to two ES related molecules. These latter molecules were 
noted to be presented upon derivatisation and injection of both individual and 
mixed standards, suggesting that they were the ES side products of the derivati-
zation. 
UV analysis of the RSSE’s obtained from the LCNaP ASF in this LC system 
revealed, in addition to the presence of cysteine, cysteinylglycine and GSH at 4, 
6.5 and 10.2 min respectively, an unidentified minor component eluting at 11.4 
min as shown in . 
The concentration of each known thiol species present in the ASF was calcu-
lated using external calibration plots after validation of the UHPLC-UV meth-
odology (see supplementary information for method validation) and is pre-
sented in . 
Thus the total concentration of the  thiols (RSSE) was estimated to 
be 11.84 femtomoles per cell, which matches closely the value of 13.10 femto-
moles per cell obtained using the traditional Ellman assay by UV spectrophoto-
metry. It is possible that the remainder of the thiols do not react with the Ellman 
reagent to produce a mixed disulfide (unpublished data). The concentration of 
the unknown was estimated using an average extinction coefficient obtained 
from the known RSSE’s. 
3.2. Identification of the Unknown by MS and NMR 
3.2.1. Mass Spectrometry Analysis 
Hyphenated MS analysis was carried out and an accurate mass of m/z 405.0058 
was obtained for the unknown minor component. An empirical formula 
C13H14N2O9S2 with an associated mass error of −0.01 ppm was derived for the 
thiol derivative in its neutral form. After addition of two protons to account for 
the disulphide bond formation and negative ionisation, the molecular formula 
for the unknown thiol in its native form (not derivatized) was deducted to be 
C6H11NO5S with a molecular weight of 209. However, the structure of this me-
tabolite could not be identified by comparison with mass spectral databases. 
In order to ascertain the thiol nature of this component and to obtain further  
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. UHPLC-UV chromatograms of standard RSSE derivatives (lower blue trace) and in the ASF of LNCaP cells (upper 
green trace). Column: SUPELCO TITAN-C18 100 × 2.1 mm, 1.8 µM; Mobile Phase: (A) H2O 0.1% v/v HCOOH, (B) MeCN 0.1% 
v/v HCOOH; Injection Volume: 1 µL; Temperature: 35˚C; Flow Rate: 0.7 ml/min; Gradient: 0 min, 100% A; 6 min, 98% A; 15 
min, 80% A; 18 min, 100% A; 20 min, 10% A; 22 min, 100% A; Post Time: 5 min; UV: 325 nm. 
 
. UHPLC quantitation of LNCaP cell RSSE components. 
RSSE components Concentration in femtomoles per cell 
Acid soluble fraction (ASF): total thiol content (Ellman assay) 13.10 ± 0.80 
GS-SE glutathione 8.30 ± 0.73 
CYS-SE cysteine 2.70 ± 0.04 
CYSGLY-SE cysteinylglycine 0.83 ± 0.10 
Unknown S-SE 0.011 (estimate) 
 
structural information, the fragmentation pattern of standard thiols derivatives 
was investigated by tandem mass spectrometry. 
MS/MS fragmentation of all standard thiol derivatives (including the Ellman 
reagent itself) systematically led to the generation of an ES fragment m/z 197.9867 
(see supplementary information). This is illustrated in  showing the UV 
trace and the extracted ion chromatogram (EIC) of the m/z 197.9867 ion (theo-
retical exact mass), obtained in negative ion mode 
This method was therefore used to investigate the fragmentation pattern of 
the unknown analyte in the LNCaP cellular extract detected by UV analysis. The 
MS/MS spectrum obtained is presented in . 
S. Childs et al. 
 
7 
 
Chromatographic traces—UV (red trace) and EIC 197.9867 (blue trace) showing the pattern obtained from standard 
mixed thiol derivatives. Column: SUPELCO TITAN-C18 100 × 2.1 mm, 1.8 µM; Mobile Phase: (A) H2O 0.1% v/v HCOOH, (B) 
MeCN 0.1% v/v HCOOH; Injection Volume: 1 µL; Temperature: 35˚C; Flow Rate: 0.7 ml/min; Gradient: 0 min, 100% A; 6 min, 
98% A; 15 min, 80% A; 18 min, 100% A; 20 min, 10% A; 22 min, 100% A; Post Time: 5 min; UV: 325 nm; MS Mode: Negative; 
Scan 50 - 1700 m/z (EIC for 197.9867). 
 
 
. MS fragmentation spectrum of the unknown derivative. 
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Two fragments were observed at 229.9589 and 197.9858 m/z, the former being 
identified as the ES-S− ion whereas the latter, corresponding to the ES ion, con-
firmed the thiol nature of the analyte ( 2). 
However, even in conjunction with the number of double bond equivalents in 
C6H11NO5S determined to be 2, the structure of the unknown thiol could not be 
identified by MS or MS/MS alone. Therefore sufficient material for an NMR 
analysis had to be generated using preparative chromatography. 
3.2.2. Identification of the Isolated Unknown by NMR Spectroscopy 
Derivatized cellular extracts from LNCaP were injected onto a semi-preparative 
column as illustrated in . 
 
. Measured m/z and MFG results for the unknown derivative. 
  [   
Unknown-SE [M-H]− 405.0058 C13H14N2O9S2 2.4 
[ES]− 197.9858 C7H5NO4S 4.3 
[ - −  C7H5NO4S2  
 
 
. UV chromatogram showing a 900 µL injection of ESSE derivatised LNCaP ASF on the semi-preparative scaled method. 
Inset: expanded region of the chromatogram between 10.5 and 13 min. 
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The purified, dried derivative was dissolved in 100% D2O and transferred to 
an NMR tube for 1H analysis. 1D proton and 2D TOCSY (not shown). Initial 
spectra were acquired as illustrated in . 
The proton NMR spectrum revealed the presence of signals integrating for a 
total of 9 non-exchangeable protons and two ABX systems suggesting the pres-
ence of two chiral centres. One of the ABX systems was assigned to a CYS moi-
ety by comparison of the signals and chemical shifts from those of a CYS-SE pu-
rified derivative. The second ABX spin system, which by deduction has a mo-
lecular formula C3H3O3, is consistent with a glycerate moiety giving signals at 
3.72 and 4.07 ppm. The signal at 3.65 ppm was excluded from the integration 
based on spectra obtained by DOSY experiment (data not shown), suggesting 
that it belonged to a molecule of a different size, hence diffusing at a different 
rate in solution. 
Further mass spectrometry analysis by direct infusion of the isolated deriva-
tive molecule dissolved in D2O:CD3OD [50:50], produced a molecular ion of 409 
m/z in negative ion mode, suggesting that the neutral molecule contains 5 ex-
changeable protons. This gives overall 14 protons which is consistent with the 
empirical formula previously determined. The assignment of the proton NMR 
signals is given in . Based on the data obtained, this new thiol metabolite  
 
 
 6. δ 8.2 - 2 ppm expanded regions of the NMR spectrum of unknown derivative obtained with 128 scans (15 min acquisi-
tion time). 
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was identified as Cysteinylglycerate (CYSGC) as shown in . The mole-
cule was suggested to be the (R,R) diastereoisomer as would be expected natu-
rally. 
4. Discussion 
Cellular thiols are recognised as playing an important role in normal cellular 
function and redox regulation through antioxidant activity. A major cell thiol, 
the low molecular weight thiol GSH, is now regarded as an important factor in 
the cellular defence against oxidative stress. The metabolism of this cysteine 
containing tripeptide has been studied in detail over the last century (for reviews 
see [10] [16]), particularly in regard to its important role in the removal of 
xenobiotics and suspected carcinogens from the cell via the glutathione trans-
ferase enzymes [17]. In addition to participating in many physiologically impor-
tant cell functions it has been shown to play an important role in in the sensitiv-
ity of tumors to the cytotoxic effects of anticancer chemotherapeutic drugs [12]. 
Unfortunately, due to the paucity of reliable analytical methods for GSH esti-
mation the results of many investigations on tumor cells have been variable and 
difficult to interpret. However, recent improvements in HPLC techniques for the 
 
. Structure of (R, R) cysteinyl glycerate derivative with assignment of the proton 
NMR signals. 
 
 
 
 
   
H4 8.03 Doublet 3J = 8.9 Hz 1.11 
H5 7.67 Doublet of doublet 3J = 8.9 Hz; 4J = 2.2 Hz 1.15 
H7 7.58 Doublet 4J = 2.2 Hz 0.82 
H8 3.1 Doublet of doublet 2J = 14.1 Hz; 3J = 8.35 Hz 1.20 
H8’ 3.35 Doublet of doublet 2J = 14.1 Hz; 3J = 4.05 Hz 1.22 
H9 4.4 Doublet of doublet 3J = 4.05 Hz; 3J = 8.35 Hz 1.00 
H12 4.1 Doublet of doublet 3J = 3.5 Hz; 3J = 5.2 Hz 1.14 
H13 3.7 Doublet of doublet 2J = 12 Hz; 3J = 3.70 Hz 
2.57 
H13’ 3.7 Doublet of doublet 2J = 12 Hz; 3J = 5.1 Hz 
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. Structure of unknown metabolite. 
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estimation of GSH [18] and other thiols, such those illustrated in this paper, 
should help greatly to elucidate the role of LMWT thiols in tumor metabolism. 
The results reported here confirm the previously reported findings of lower 
percentage GSH content in the acid soluble fraction of LNCaP cells than usually 
found in other cells [7]. The amount of GSH present in the ASF was higher than 
previously found; possibly due to 2 hours re-incubation of confluent cells in 
fresh medium employed before harvesting. However the presence of significant 
quantities of cysteine (which usually quickly incorporated into GSH) and cys-
teinylglycine indicates that abnormal/aberrant GSH metabolic pathways exist in 
this tumor cell line [19]. In the normal cellular synthesis of GSH the only cys-
teinyl dipeptide involved is γ-glutamylcysteine; GSH synthetase adds glycine to 
this to give the tripeptide. Free dipeptide cysteinylglycine is not normally present 
and if formed it is broken down by a dipeptidase to generate cysteine and gly-
cine. The only enzyme that can hydrolyse GSH, removing the glutamate to give 
cysteinylglycine, is γ-glutamyltranspeptidase which is only present on the exter-
nal surfaces of certain cell types [20]. 
Whether this pattern of low molecular weight thiols is a characteristic of 
lymph node metastatic cells in general is yet to be ascertained. However, in a 
study of human prostate cells obtained from clinical biopsy samples Chaiswing 
et al. [21] demonstrated a decrease in GSH (using an enzyme assay) and an in-
crease in cysteine levels in these samples with increasing Gleason scores (a clini-
cal measure of an increased presence of malignant cells). They attributed this to 
redox imbalance occurring with prostate cancer progression. They concluded 
that, as treatment of metastatic cancer is generally unsuccessful, further knowl-
edge of redox-state profiles in these cancers may help to predict their behaviour 
and response to chemotherapeutic drugs and radiation. 
The presence of a new metabolite, cysteinylglycerate, albeit in small quantities, 
may be due to a defect in the usual phosphoglycerate pathways; phosphoglycer-
ates are important biochemical intermediates in glycolysis. Increased glycolysis 
is a feature of the well-known Warburg effect of increased anaerobic respiration 
found in most tumour cells [22] though there have been no reports of glycerate 
being involved with thiol metabolism. 
Cysteinylglycerate might prove to be a useful biomarker for this kind of tu-
mour, however further metabolomic investigations are needed to establish the 
biochemical relevance of this new metabolite in the overall biochemistry of 
lymph node metastatic cells and to evaluate its diagnostic potential. 
5. Conclusion 
Using the Ellman reagent as a label for the LMWT present in LNCaP metastatic 
tumor cells, we have identified 4 components. In ascending order of concentra-
tion, they are glutathione, cysteine, cysteinylglycine and cysteinylglycerate. Fur-
ther, metabolomic investigations are needed to establish their importance in the 
overall biochemistry of lymph node metastatic cell. This knowledge may aid the 
development of new chemotherapeutic agents to treat metastatic tumours that 
S. Childs et al. 
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are resistant to radiation and cannot be effectively removed by surgery. 
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1. Supplementary Information 
1.1. Method Validation for UV Quantification 
The achieved chromatographic resolution of derivatised thiol standards and the 
use of a specific wavelength for derivative moieties ensured the suitable selectiv-
ity of this method for analysis of LNCaP cellular thiols. 
1.2. Determination of Lower Limits of Detection 
The lower limits of detection were established for each derivative standard by 
sequentially reducing the concentration of standard thiol injected onto the col-
umn until a signal to noise ratio (S:N) of 3:1 was observed. Triplicate injections 
at the LLOD concentration were performed to confirm these values. The LLOD 
was determined to be 2.1 µM for CYS-SE, 1.6 µM for GS-SE and 2.7 µM for 
CYSGLY-SE 
1.3. Determination of Lower Limits of Quantitation (LLOQ) & 
Intraday Precision 
The lower limits of quantitation and intraday precision were assessed simulta-
neously by measuring 8 repeat injections at the concentration deemed to be the 
lower limit of quantitation. This concentration gave a peak area response with a 
coefficient of variation less than 3% for the derivatised standards and therefore is 
a suitable LLOQ as illustrated in . 
1.4. Determination of Interday Precision 
Interday precision was assessed to ascertain the stability of the method over an 
extended period of time with respect to the peak response and retention time of 
the thiol derivatives in the sample. Freshly prepared derivatised LNCaP cellular 
extract was injected six times over six consecutive days and was stored at ambi-
ent temperature in the autosampler between days. The coefficient of variation 
was determined for each derivative analyte over the course of the validation as 
shown in . 
The coefficients of variation for retention time and peak area of the analytes 
are shown to be less than 10% and therefore are within the criteria limits for 
biological method validation. 
1.5. Determination of Linearity 
Linearity was assessed for each standard derivative by injecting a mixed standard  
 
. LLOQ & intraday precision results. 
 
-  -  -  
 0.0083 0.0066 0.0053 
 4.04 3.94 2.24 
 0.048 0.070 0.048 
 1.199 1.768 2.164 
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over a range of concentrations span from the LLOQ to a concentration at which 
the response is no longer deemed to be linear, indicated by a decrease in the R2 
value of the trend line. The linear ranges determined demonstrate high R2 val-
ues, indicating the high accuracy of this method. The linearity assay conforms to 
the FDA standard of a minimum of five data points across the linear range as il-
lustrated in . 
1.6. Mass Spectrometry Analysis 
 
Analysing the RSSE thiol derivatives standards by MS in negative mode sys-
tematically yielded a fragment at 197.9873 m/z through in source fragmentation. 
Example MS spectra obtained with GSH-SE and an ES related impurity gener-
ated during the derivatisation process are shown in . The proposed 
structure of the ES related impurity matched the observed mass with a ppm dif-
ference of 3.03. This indicates a very close agreement. 
Further MS/MS studies showed that the 197.9873 fragment arose specifically 
from the RSSE derivatives. In order to elucidate the unknown thiol the process 
of determining the molecular formula was investigated initially using the glu-
tathione derivative. Using the observed mass difference between the derivative 
molecular ion and the TNB fragment provided the accurate mass of the thiol 
molecule, absent a proton from ionisation and another from cleavage of the di-
sulphide bond ( ). 
Molecular formula generation was also used to confirm the protocol had iden-
tified the correct fragment by comparing with the known molecular formula as 
shown in . 
Following the rationale that the unknown molecule fragments similarly GS-SE 
as shown in the previous figure, the molecular formula of the un-derivatised 
molecule was calculated by measurement of the mass difference and calculation 
of the best fitting molecular formula as shown in  and . 
 
. Interday precision results. 
 
  
 
-  -  -  -  -  -  
 47.29 36.69 87.63 1.17 2.92 3.95 
 1.666 2.407 2.185 0.054 0.075 0.071 
 3.523 6.560 2.494 4.596 2.551 1.811 
 
. Linearity results for derivative standards. 
 
 
-  -  -  
 0.0083 0.0066 0.0053 
 1.0657 0.8422 0.6785 
R2 1 0.999 1 
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. MS spectra of GSSE (top) and ES peak (bottom), with proposed fragment structure (inset). 
 
 
. Negative mode fragmentation spectrum of GS-SE. 
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. Measured m/z and MFG results for GS-SE. 
  [M- − [   [  
-  503.0537 C17H20N4O10S2 2.20 C17H20N4O10S2 
 197.9864 C7H5NO4S 1.27 C7H5NO4S 
- -   ) C H N3O6  ) - C H N3O6S 
 
 . Measured m/z and MFG results for the unknown derivative. 
  [M- − [   
-  405.0058 C13H14N2O9S2 2.4 
 197.9858 C7H5NO4S 4.3 
- -   C6H9 5S  
 
 
. MS fragmentation spectrum of unknown derivative. 
 
The results showed that the molecular formula for the unknown thiol species 
is proposed to be C6H11NO5S after the addition of two protons to account for 
bond cleavage and negative ionisation. 
 
For illustration, a list of the corresponding molecular ions and fragments 
observed by MS with source fragmentation from a mixture of standard RSSE’s 
is given in . These results confirm the identity of the standard thiol 
RSSE’s. 
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. Corresponding molecular ions and fragments by positive mode MS analysis. 
 [M + +  1   
-  
S
O
HO
O2N
NH3
O
OHS
 
C10H10N2O6S2 319.0053 
300.9949 
 272.9998 
 120.0112 
-  
NH3
O
HO
S
O
OH
NO2
N
H
O
O
H
N
S
O
OH
 
C17H20N4O10S2 505.0694 
 430.0373 
-  376.0268 
 272.9998 
-  NH3
O
N
H
S
O
OH
S
O
HO
O2N  
C12H13N3O7S2 376.0268  272.9998 
-  S
O
HO
O2N
S
NH3
O
OH
 
C11H12N2O6S2 333.0210  287.0155 
-  
S
O
HO
O2N
S
NH3
 
C9H10N2O4S2 275.0155 
257.9895 
229.9583 
2. Abbreviations 
CYS: L-cysteine; CYSGLY: cysteinylglycine,; CYSAM: cysteamine; ES: 5-thio-2- 
nitrobenzoic acid; ESSE: 5’5 dithiobis(-2-nitrobenzoic acid); DTNB: 5’5 dithio-
bis(-2-nitrobenzoic acid); HCYS: homocysteine; LMWT: Low molecular weight 
thiols; GSH: glutathione; PCa: prostate cancer; TCA: trichloroacetic acid; TIC: 
total ion count. 
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